Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 4,666 shares at $52.73 ($243K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $243k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.36 | 800 | $40K | 16.5% |
| 2 | $51.58 | 600 | $31K | 12.7% |
| 3 | $52.73 | 1,583 | $83K | 34.3% |
| 4 | $52.73 | 1,583 | $83K | 34.3% |
| 5 | $53.20 | 100 | $5K | 2.2% |
| Total | $52.19 avg | 4,666 |
| $243K |
| 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |